To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.


Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Written Question
Israel: Palestinians
Thursday 23rd May 2024

Asked by: Baroness Ritchie of Downpatrick (Labour - Life peer)

Question to the Foreign, Commonwealth & Development Office:

To ask His Majesty's Government whether they plan to sanction (1) Israeli government ministers, Itamar Ben-Gvir and Bezalel Smotrich, and (2) leaders of the settler movement, who have expressed support for acts of violence against (a) Palestinians, (b) aid workers and convoys, and (c) UNRWA facilities.

Answered by Lord Ahmad of Wimbledon

The UK policy on settlement expansion is clear: settlements are illegal under international law and only make it harder to progress to achieving peace and security for Israelis and Palestinians. We have called on the Israeli Government to halt seizures of Palestinian lands immediately.

On 3 May, the Foreign Secretary announced new sanctions on extremist groups and individuals for inciting and perpetrating settler violence in the West Bank. The measures impose financial restrictions on the entities and individuals, and travel restrictions on the individuals. The UK will not hesitate to take further action if needed, including through further sanctions.

The Foreign Secretary has made our position clear to his Israeli counterparts, including during his visit to the region on 17 April.


Written Question
Deep Sea Mining: Norway
Thursday 23rd May 2024

Asked by: Baroness Ritchie of Downpatrick (Labour - Life peer)

Question to the Department for Business and Trade:

To ask His Majesty's Government what discussions they have had with the government of Norway concerning that country's announcement that it will start exploratory deep seabed mining in its waters; and what assessment they have made of the impact this would have on wider North-eastern Atlantic fisheries.

Answered by Lord Offord of Garvel

The UK Government has not spoken to the Norwegian government about its decision of 9 January 2024 to consider awarding licences for deep sea mining exploration, and potentially future extraction, on its continental shelf but has taken note of the decision. This area is within Norway's jurisdiction and is not regulated by the International Seabed Authority.


Written Question
Universal Credit
Wednesday 22nd May 2024

Asked by: Baroness Ritchie of Downpatrick (Labour - Life peer)

Question to the Department for Work and Pensions:

To ask His Majesty's Government what the percentage of people who moved to Universal Credit under the 'Move to UC' policy have been awarded 'transitional protection' (1) between 1 April 2023 and 31 March 2024, and (2) between 1 to 30 April 2024.

Answered by Viscount Younger of Leckie

The latest published statistics show for households sent a migration notice between April 2023 and end of March 2024, and who went on to claim Universal Credit, 60% were awarded transitional protection.

The relevant information can be found in ‘table 9a’ published here: Move to Universal Credit statistics, July 2022 to March 2024 - GOV.UK (www.gov.uk)

Data for April 2024 will be published as part of the next Move to Universal Credit statistics release.


Written Question
Bowel Cancer: Screening
Monday 20th May 2024

Asked by: Baroness Ritchie of Downpatrick (Labour - Life peer)

Question to the Department of Health and Social Care:

To ask His Majesty's Government whether they plan to support NHS England’s pilot to reduce the faecal immunochemical test threshold for the Bowel Cancer Screening Programme from 120µg/g to 80µg/g; and whether they have had discussions with NHS England regarding geographical areas for the pilot.

Answered by Lord Markham

We are committed to improving the NHS Bowel Screening programme, and welcome NHS England’s plans for pilot areas, which will reduce the faecal immunochemical test (FIT) down to 80µg/g. NHS England plans to publish an Expression of Interest to give all bowel screening services, and their partner symptomatic endoscopy providers, an opportunity to submit their interest in becoming a FIT@80 pilot site. These pilot sites are planned to be selected and launched later in 2024/25, and attention will be paid to ensure there is regional variation across the pilot sites selected.


Written Question
Radiotherapy: Staff
Monday 20th May 2024

Asked by: Baroness Ritchie of Downpatrick (Labour - Life peer)

Question to the Department of Health and Social Care:

To ask His Majesty's Government, further to the Royal College of Radiologists report Clinical Radiology Workforce Census 2022, published on 8 June 2023, what steps they will take to address the shortfall in clinical oncologists in England.

Answered by Lord Markham

The NHS Long Term Workforce Plan (LTWP) sets out the steps the National Health Service and its partners need to take to deliver an NHS workforce that meets the changing needs of the population over the next 15 years. It will put the workforce on a sustainable footing for the long term.

We are building our cancer workforce. In January 2024 there were over 35,200 full-time equivalent (FTE) staff in the cancer workforce, an increase of over 13,300, or 60.7% since January 2010.

Regarding clinical oncology specifically, as of January 2024, there are currently over 1,600 FTE doctors working in the speciality of clinical oncology in NHS trusts and other core organisations in England. This is 2.2% more than last year, 27.7% more than 2019, and 66.5% more than in 2010. This includes over 900 FTE consultants. This is 5.1% more than last year, 22.0% more than in 2019, and 80.2% more than in 2010.


Written Question
Radiotherapy: Standards
Monday 20th May 2024

Asked by: Baroness Ritchie of Downpatrick (Labour - Life peer)

Question to the Department of Health and Social Care:

To ask His Majesty's Government, further to (1) the recent Royal College of Radiologists’ Radiotherapy Briefing, published in May, and (2) the HERO (Health Economics in Radiation Oncology) report by the UK Radiotherapy Board, published on 2 May, what is their current assessment of the state of radiotherapy services in England.

Answered by Lord Markham

According to the latest data, of those 10,328 cancer patients referred for first or subsequent treatment for radiotherapy in March 2024, 89.7% were treated within 31 days. Since 2016, there has been significant investment in radiotherapy equipment, so that every radiotherapy provider had access to modern, cutting-edge radiotherapy equipment, enabling the rollout of new techniques like stereotactic ablative radiotherapy. The total central investment made between 2016 and 2021 was £162 million, and enabled the replacement or upgrade of approximately 100 radiotherapy treatment machines. This is investment on top of that committed by National Health Service trusts, either from their own capital budgets or via donations.

From April 2022, the responsibility for investing in new radiotherapy machines sits with local systems. As outlined in the 2024/25 NHS Planning Guidance, NHS England is providing over £266 million in cancer service development funding to Cancer Alliances, to support delivery of the operational priorities for cancer. This is supported by the 2021 Spending Review, which set aside £12 billion in operational capital for the NHS.

The Department is working closely with NHS England to make sure we have the right workforce with the right skills up and down the country. We are building our cancer workforce. In January 2024 there were over 35,200 full-time equivalent staff in the cancer workforce, an increase of over 13,300, or 60.7% since January 2010.


Written Question
Radiotherapy: Standards
Monday 20th May 2024

Asked by: Baroness Ritchie of Downpatrick (Labour - Life peer)

Question to the Department of Health and Social Care:

To ask His Majesty's Government what progress they have made towards ensuring that people with cancer who require radiotherapy treatment can start treatment within their target of 31 days.

Answered by Lord Markham

We are seeing continued high levels of urgent cancer referrals, with over 12,000 urgent referrals seen for suspected cancer per working day in March 2024, compared to approximately 9,000 in March 2019. In March 2023, 89.7% of patients received a first or subsequent radiotherapy treatment within 31 days of a decision to treat, which is 0.6% higher than last year. From March 2023/24, 127,336 people received a first or subsequent radiotherapy treatment, which is 1,359 more than the previous year.

The Government continues to work with NHS England on implementing the Delivery plan for tackling the COVID-19 backlog of elective care, and plans to spend more than £8 billion from 2022/23 to 2024/25 to help drive up and protect elective activity, including cancer diagnosis and treatment activity.

We are building our cancer workforce. In January 2024 there were over 35,200 full-time equivalent (FTE) staff in the cancer workforce, an increase of over 13,300, or 60.7% since January 2010. This includes over 8,100 FTE consultants in January 2024, an increase of over 3,300, or 69.6% since January 2010.

Since 2016, the Department has invested £162 million into cutting-edge radiotherapy equipment to replace or upgrade more than 100 radiotherapy treatment machines, so we can deliver the best possible outcomes for patients. From April 2022, the responsibility for investing in new radiotherapy machines sits with local systems.


Written Question
Cancer: Health Services
Monday 20th May 2024

Asked by: Baroness Ritchie of Downpatrick (Labour - Life peer)

Question to the Department of Health and Social Care:

To ask His Majesty's Government what steps they are taking to meet their target of 96 per cent of cancer patients receiving treatment within 31 days of a decision to treat.

Answered by Lord Markham

Tackling cancer is a key priority for the Government. Ministers and officials continue to work closely with NHS England to increase positive outcomes for all cancer types. The Government has allocated an additional £8 billion across this Spending Review period, to increase capacity and support elective recovery.

As outlined in the 2024/25 NHS Planning Guidance, NHS England are providing over £266 million in cancer service development funding to Cancer Alliances to support delivery of the operational priorities for cancer, increasing and prioritising diagnostic and treatment capacity.

We are building our cancer workforce. In January 2024 there were over 35,200 full-time equivalent (FTE) staff in the cancer workforce, an increase of over 13,300, or 60.7%, since January 2010. This includes over 8,100 FTE consultants in January 2024, an increase of over 3,300, or 69.6%, since January 2010.


Written Question
Radiotherapy: Expenditure
Monday 20th May 2024

Asked by: Baroness Ritchie of Downpatrick (Labour - Life peer)

Question to the Department of Health and Social Care:

To ask His Majesty's Government what was the total amount spent by the NHS on radiotherapy services in England in the past year, broken down by (1) region, and (2) NHS trust.

Answered by Lord Markham

Whilst data for the past year is not yet available, the latest published data on radiotherapy costs is from the National Health Service national cost collection for 2021/22, where spend is reported as £550 million. More detailed data by the NHS trusts is also available at the NHS website, in an online only format.


Written Question
Health: Productivity
Monday 20th May 2024

Asked by: Baroness Ritchie of Downpatrick (Labour - Life peer)

Question to the Department of Health and Social Care:

To ask His Majesty's Government what plans they have to enable evaluation of health programmes and investments to account for productivity benefits, in line with guidance issued in the Green Book.

Answered by Lord Markham

The Department has well-established policies and mechanisms in place to ensure health programmes and investments are subject to systematic evaluation at key stages in their lifecycle, in accordance with HM Treasury’s business case guidance. This includes reviewing quantitative and qualitative evidence on whether approved health projects achieve their objectives and deliver the promised benefits within the agreed budget, timescale, and scope. Lessons from post-project evaluation are widely disseminated, to support better investment decisions in future, and more robustly developed business cases.